An Oklahoma City federal court ruled Wednesday that the Oklahoma Medical Research Foundation may proceed with legal action against pharmaceutical giant Eli Lilly and Company for patent infringement, fraud, constructive fraud and unjust enrichment. The lawsuit involves a treatment for severe sepsis, sometimes referred to as “blood poisoning”, which kills more than 215,000 people each […]
scientist-news
Cason to Head Board of Directors at OMRF
Oklahoma City, OK – The Oklahoma Medical Research Foundation announced that Len Cason has been elected Chairman of the Board of Directors during its annual meeting today. Cason has been an attorney with the Oklahoma City firm of Hartzog Conger Cason and Neville for the past thirteen years. He has been a member of OMRF’s […]
OMRF HOSTS FIRST INTERNATIONAL LUPUS GENETICS CONFERENCE
Oklahoma City, OK – The Oklahoma Medical Research Foundation hosted the first international Lupus genetics conference on September 8-9. Although scientists have been using modern approaches to study the genetics of Lupus for the past ten years, there has never been a formal meeting dedicated to the subject. This meeting was meant to facilitate meetings […]
Researchers Seek Candidates for Breast Cancer Study
Oklahoma City, OK – Following the discovery of a new gene potentially associated with breast cancer, Oklahoma City researchers announced they are seeking candidates for an ongoing study to further analyze the genetics of the disease. This announcement follows the publication of a study in the prestigious British medical journal The Lancet on May 19, […]
Oklahoma Researchers Discover New Gene Potentially Associated with Breast Cancer
Oklahoma City, OK – Young women concerned about their risk for breast cancer may soon have another test to aid them in early detection or prevention of the disease, thanks to the discovery of another gene that appears to be associated with breast cancer in women age 50 and younger who have a family history […]
OMRF Researchers Discover Limitin A new interferon-like substance
(OKLAHOMA CITY) — Scientists at the Oklahoma Medical Research Foundation (OMRF) have announced the discovery of a new interferon-like substance they named “limitin” because of its ability to limit tumor cell growth. Limitin is partially similar in structure to the type I interferons, naturally occurring proteins first discovered for their ability to curtail viral replication. […]
